The coronavirus demands a lot of everyone's attention and its consequences have an effect on research in the rheumatology field. In hospitals, the reception and care of coronavirus patients requires the utmost attention from healthcare professionals, which will continue for the time being. This puts pressure on the submission and assessment of project applications. The Dutch Reumafonds finds it important that researchers are given sufficient space to submit a project application and that the assessment of project applications can be carried out carefully by experts. In addition, Reumafonds in the Netherlands faces a major financial setback because the collection did not take place in March 2020. For these reasons, it has been decided to move the 2020 calls. The deadline for submitting late translational/clinical project proposals was 15 May 2020 and will be 14 August 2020 at noon. Project applications will be awarded in March/April 2021. The deadline for submission of fundamental/ early translational project proposals was 1 December 2020 and will be postponed to 15 May 2021 at noon. Granting of project applications will take place in January 2022. Further information on the project conditions and the forms can be found on the website. In the meantime, it has also become clear that studies that have already been started may be delayed because it is virtually impossible to work in the laboratories and/or the inclusion of patients has (partially) come to a standstill. Moreover, projects that have recently been awarded may not be able to start on time. In case of a delay or inability to start your project, we ask you to contact the Research and Innovation department as soon as possible via the following e-mail addres: email@example.com. Reumafonds will be happy to help you find a solution. A budget-neutral extension is one of the possibilities. Reumafonds will process this as soon as there is insight into what a real extension period is.